Ocular Therapeutix (OCUL) EBT Margin (2014 - 2026)
Ocular Therapeutix (OCUL) reported EBT Margin of -589.63% for Q2 2026, down 90.32 percentage points from -499.31% a year earlier but up 245.49 percentage points from the prior quarter.
Powered by 
Analysis
Ocular Therapeutix (OCUL) EBT Margin (2014 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Ocular Therapeutix's EBT Margin came in at -581.59%, down 188.29 percentage points year-over-year; for FY2025, it was -507.20%, down 248.15 percentage points from FY2024.
- EBT Margin has a five-year change of -108.15 percentage points (FY2020 to FY2025).
- By year, EBT Margin came in at -259.05% in FY2024 (-105.51 pp), -153.55% in FY2023 (+11.28 pp), -164.83% in FY2022 (+29.73 pp) and -194.56% in FY2021 (+204.50 pp).
- Five-year quarterly EBT Margin spans a low of -835.11% in Q1 2026 and a high of -142.09% in Q3 2023.
- Year over year, EBT Margin has now declined in each of the last 11 quarters, with an average year-over-year change of -203.26 percentage points over the last eight quarters.
- The high point for year-over-year EBT Margin in five years was Q1 2022 (a gain of 150.36 percentage points); the low point was Q1 2025 (a drop of 374.72 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -835.11% (Q1 2026), -492.45% (Q4 2025) and -467.35% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn | 29.63% |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn | 18.19% |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn | 27.53% |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn | -131.41% |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn | -4.34% |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn | 41.75% |
| 10 | Ocular Therapeutix | 2.12 Bn | 2.12 Bn | 11.46 Mn | -589.63% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -589.63% |
| Mar 31, 2026 | -835.11% |
| Dec 31, 2025 | -492.45% |
| Sep 30, 2025 | -467.35% |
| Jun 30, 2025 | -499.31% |
| Mar 31, 2025 | -589.60% |
| Dec 31, 2024 | -286.92% |
| Sep 30, 2024 | -282.46% |
| Jun 30, 2024 | -247.86% |
| Mar 31, 2024 | -214.88% |
| Dec 31, 2023 | -153.65% |
| Sep 30, 2023 | -142.09% |
| Jun 30, 2023 | -143.64% |
| Mar 31, 2023 | -177.61% |
| Dec 31, 2022 | -147.67% |
| Sep 30, 2022 | -192.70% |
| Jun 30, 2022 | -175.60% |
| Mar 31, 2022 | -147.86% |
| Dec 31, 2021 | -160.25% |
| Sep 30, 2021 | -174.28% |
API Access
Ocular Therapeutix EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=OCUL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "OCUL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=OCUL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();